Efficacy and Safety of Ivabradine Once-daily Prolonged Release versus Twice-daily Immediate Release Formulation in Patients with Stable Chronic Heart Failure with Systolic Dysfunction – A Randomized, Double-blind, Phase 3, Non-Inferiority (PROFICIENT) Study

<p>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> <p>© The authors, CC-BY-NC 2020.</p>